TPTX
Turning Point Therapeutics, Inc.
Total Trades
11
Buys
0
Sells
6
Largest Trade
N/A
Insiders
6
Institutional Funds
6
Inst. Value
$1M+
Activist Filings
2
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| TOMBESI PAOLO | CFO | SELL | $50K–$100K | 1K | $74.94 | Jul 29, 2022 |
| Reich Siegfried | EVP & Chief Scient… | GRANT | N/A | 14K | — | Feb 11, 2022 |
| Reich Siegfried | EVP & Chief Scient… | SELL | $1K–$15K | 397 | $36.30 | Feb 11, 2022 |
| Partridge Andrew John | EVP & Chief Commer… | GRANT | N/A | 16K | — | Feb 11, 2022 |
| Partridge Andrew John | EVP & Chief Commer… | SELL | $1K–$15K | 221 | $36.30 | Feb 11, 2022 |
| North Annette | EVP & General Coun… | GRANT | N/A | 16K | — | Feb 11, 2022 |
| North Annette | EVP & General Coun… | SELL | $15K–$50K | 669 | $36.30 | Feb 11, 2022 |
| Hirmand Mohammad | EVP & Chief Medica… | SELL | $15K–$50K | 669 | $36.30 | Feb 11, 2022 |
| Hirmand Mohammad | EVP & Chief Medica… | GRANT | N/A | 34K | — | Feb 11, 2022 |
| Countouriotis Athena | President & CEO | SELL | $100K–$500K | 3K | $36.30 | Feb 11, 2022 |
| Countouriotis Athena | President & CEO | GRANT | N/A | 62K | — | Feb 11, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Jun 30, 2022 · 6 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| FEDERATED HERMES, INC. | 919K | $1M+ | SH |
| PRELUDE CAPITAL MANAGEMENT, LLC | 69K | $1M+ | SH |
| Verition Fund Management LLC | 4K | $100K–$500K | SH |
| METROPOLITAN LIFE INSURANCE CO/NY | 3K | $100K–$500K | SH |
| Amundi | 2K | $100K–$500K | SH |
| CAPTRUST FINANCIAL ADVISORS | 195 | $15K–$50K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Cormorant Global Healthcare Master Fund, LP
SC 13G · Feb 14, 2022
3.1%
1.5M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2022
7.7%
3.8M shares